Chronic antifibrotic and hemodynamic effects of a new liver specific no donor (V-PYRRO/NO) in bile duct ligated (BDL) rats.

被引：0
|
作者：
Moal, F [1 ]
Vuillemin, E [1 ]
Wang, JH [1 ]
Veal, N [1 ]
Oberti, F [1 ]
Cales, P [1 ]
机构：
[1] Univ Angers, Angers, France
来源：
HEPATOLOGY | 2000年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
94
引用
收藏
页码：186A / 186A
页数：1
相关论文
共 48 条
  • [31] The liver-specific nitric oxide donor V-PYRRO/NO protects HepG2 cells against cytochrome P450 2EI-dependent toxicity.
    Gong, PF
    Cederbaum, AI
    Nieto, N
    HEPATOLOGY, 2002, 36 (04) : 332A - 332A
  • [32] Neurological Dysfunction Is Improved After Faecal Microbiota Transplantation in Rats With Bile Duct Ligated-Induced Chronic Liver Disease
    Bourgeois, Alexandre
    Veillette, Felix
    Oliveira, Mariana
    Dubois, Karine
    Tremblay, Melanie
    Bemeur, Chantal
    Rose, Christopher F.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (9S): : S23 - S24
  • [33] Neurological dysfunction is improved after faecal microbiota transplantation in rats with bile duct ligated-induced chronic liver disease
    Bourgeois, Alexandre
    Veillette, Felix
    Oliveira, Mariana
    Dubois, Karine
    Tremblay, Melanie
    Marette, Andre
    Bemeur, Chantal
    Rose, Christopher F.
    JOURNAL OF HEPATOLOGY, 2023, 78 : S233 - S233
  • [34] Chronic administration of aminoguanidine reduces vascular nitric oxide production and attenuates liver damage in bile duct-ligated rats
    Wei, CL
    Hon, WM
    Lee, KH
    Khoo, HE
    LIVER INTERNATIONAL, 2005, 25 (03) : 647 - 656
  • [35] Ablation of the D2 dopaminergic innervation by intraportal injection of 6-hydroxidopamine (6-OHDA) reduces cholangiocyte proliferative and secretory activity in bile duct ligated (BDL) rats.
    Glaser, S
    Lesage, G
    Alvaro, D
    Chowdury, U
    Kanno, N
    Francis, H
    Eisel, W
    Alpini, G
    HEPATOLOGY, 1999, 30 (04) : 432A - 432A
  • [36] Effects of a new bioactive lipid-based drug carrier on cultured hepatic stellate cells and liver fibrosis in bile duct-ligated rats
    Adrian, Joanna E.
    Poelstra, Klaas
    Scherphof, Gerrit L.
    Meijer, Dirk K. F.
    van Loenen-Weemaes, Anne-miek
    Reker-Smit, Catharina
    Morselt, Henriette W. M.
    Zwiers, Peter
    Kamps, Jan A. A. M.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 321 (02): : 536 - 543
  • [37] Organ specific regulation of 11beta-hydroxysteroid dehydrogenase type 2 in bile duct ligated rats with decompensated liver cirrhosis
    Thiesson, HC
    Jensen, BL
    Skoett, O
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 491A - 491A
  • [38] Serum metabonomics characterization of liver fibrosis induced by bile duct-ligated in rats and the intervention effects of herb compound 861
    Liu, Xiao-Jie
    Zhang, Cong-En
    Yu, Xiao-Hong
    Liu, Rui-Xia
    Qin, Xue-Mei
    Jia, Ji-Dong
    Ma, Zhi-Jie
    JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, 2019, 42 (1-2) : 31 - 44
  • [39] Neutralization of vascular endothelial growth Factor C (VEGF-C) by chronic administration of ANTI-VEGF-C antibody inhibits cholangiocyte proliferation and secretin-stimulated ductal secretion of bile duct ligated (BDL) rats.
    Barbaro, B
    Glaser, S
    Gaudio, E
    Francis, H
    Marzioni, M
    Venter, J
    Stoica, G
    Ueno, Y
    Baumann, B
    Franchitto, A
    Onori, P
    Phinizy, JL
    LeSage, G
    Alpini, G
    HEPATOLOGY, 2002, 36 (04) : 224A - 224A
  • [40] THE ROLE OF TOLL-LIKE RECEPTORS 2 AND 4 IN MEDIATING SUSCEPTIBILITY TO ACUTE-ON-CHRONIC LIVER FAILURE IN BILE DUCT LIGATED RATS
    Shah, Naina
    Davies, Nathan
    Vairappan, Balasubramaniyan
    Wright, Gavin
    Mookerjee, Rajeshwar P.
    Jalan, Rajiv
    HEPATOLOGY, 2008, 48 (04) : 1019A - 1020A
12345